Structural basis for the inhibition of coronaviral main proteases by PF-00835231 by Zhou Xuelan, Lu Xiaolu, Lin Cheng, Zou Xiaofang, Li Wenwen, Zeng Xiangyi, Wang Jie, Zeng Pei, Wang Weiwei, Zhang Jin, Jiang Haihai, Li Jian

Subjects: Get full text

Identification of compounds from natural Peruvian sources as potential inhibitors of SARS-CoV-2 Mpro mutations by virtual screening and computational simulations [version 3; peer r... by Haruna Luz Barazorda-Ccahuana, Miguel Angel Chavez-Fumagalli, Margot Paco-Chipana, Luis Daniel Goyzueta-Mamani, Eymi Gladys Cárcamo Rodriguez, Angela Emperatriz Centeno-Lopez

Subjects: “…Main protease…”
Get full text

Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis by EBENEZER OLUWAKEMI, BODEDE OLUSOLA, AWOLADE PAUL, JORDAAN MARYAM A., OGUNSAKIN ROPO E., SHAPI MICHAEL

Subjects: “…covid-19 main protease…”
Get full text

Promising inhibitors against main protease of SARS CoV-2 from medicinal plants: In silico identification by EBENEZER OLUWAKEMI, SHAPI MICHAEL

Subjects: “…sars cov-2 main protease inhibitors…”
Get full text

Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies by Daoud Safa, Alabed Shada J., Dahabiyeh Lina A.

Subjects: Get full text

Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease by Kejia Zhang, Patrick Eldin, Jessica H Ciesla, Laurence Briant, Jenna M Lentini, Jillian Ramos, Justin Cobb, Joshua Munger, Dragony Fu

Subjects: Get full text

Identification of potential corticosteroid binding sites on the SARS CoV-2 main protease Mpro — in silico docking study by Н. В. Хміль, А. В. Шестопалова, В. Г. Колесніков, А. О. Боєчко-Немовча

Subjects: Get full text

Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 Management by Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonjabulo Ntombikhona Magwaza, Nonkululeko Avril Mbatha, Tambwe Willy Muzumbukilwa, Mukanda Gedeon Kadima, Fave Yohanna Tata, Mthokosizi Bongani Nxumalo, Riziki Ghislain Manimani, Ntabaza Ndage, Bakari Salvius Amuri, Kahumba Byanga, Manimbulu Nlooto, Rene B. Khan, Hezekiel M. Kumalo

Subjects: Get full text

Miniaturized Modular Click Chemistry‐enabled Rapid Discovery of Unique SARS‐CoV‐2 Mpro Inhibitors With Robust Potency and Drug‐like Profile by Mianling Yang, Myoung Kyu Lee, Shenghua Gao, Letian Song, Hye‐Yeon Jang, Inseong Jo, Chun‐Chiao Yang, Katharina Sylvester, Chunkyu Ko, Shuo Wang, Bing Ye, Kai Tang, Junyi Li, Manyu Gu, Christa E. Müller, Norbert Sträter, Xinyong Liu, Meehyein Kim, Peng Zhan

Subjects: Get full text

In silico binding role of flavonoids as SARS-CoV-2 main protease (Mpro) inhibitors: A dataset of molecular docking simulation-based high-throughput virtual screening (HTVS)Mendeley... by Mariyam Eema, Vasudeva Rao Avupati

Subjects: Get full text

Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19 by Karol Biernacki, Olga Ciupak, Mateusz Daśko, Janusz Rachon, Damian Flis, Justyna Budka, Iwona Inkielewicz-Stępniak, Anna Czaja, Janusz Rak, Sebastian Demkowicz

Subjects: Get full text

Identification of the most potent bioactive natural compound as main protease inhibitor of SARS-CoV-2: Molecular docking, molecular dynamics simulations and MM-PBSA studies by Sana Begum, Vishal K. Singh, Priyanka Kumari, et al.

Subjects: Get full text

Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 M^pro by Jiayi Ren, Zhengfu Zhang, Yi Xia, Daqun Zhao, Dingqin Li, Shujun Zhang

Subjects: Get full text

Benzocarbazoledinones as SARS-CoV-2 Replication Inhibitors: Synthesis, Cell-Based Studies, Enzyme Inhibition, Molecular Modeling, and Pharmacokinetics Insights by Luana G. de Souza, Eduarda A. Penna, Alice S. Rosa, Juliana C. da Silva, Edgar Schaeffer, Juliana V. Guimarães, Dennis M. de Paiva, Vinicius C. de Souza, Vivian Neuza S. Ferreira, Daniel D. C. Souza, Sylvia Roxo, Giovanna B. Conceição, Larissa E. C. Constant, Giovanna B. Frenzel, Matheus J. N. Landim, Maria Luiza P. Baltazar, Celimar Cinézia Silva, Ana Laura Macedo Brand, Julia Santos Nunes, Tadeu L. Montagnoli, Gisele Zapata-Sudo, Marina Amaral Alves, Diego Allonso, Priscila V. Z. Capriles Goliatt, Milene D. Miranda, Alcides J. M. da Silva

Subjects: Get full text

Herbal-based tea bag reduces SARS-CoV-2 variant symptoms and infection duration via microRNA regulation: Clinical and mechanistic insights by Kai-Wei Chang, Yen-Ying Kung, Shu-Ling Fu, Ju-Fang Liu, Kun-Chang Wu, Tzu-Hau Shi, Yu-Han Luo, Chao-Hsiung Lin, Jih-Jung Chen, Yueh-Hsin Ping, Tung-Hu Tsai, Muh-Hwa Yang

Subjects: Get full text

High-throughput screening of dual-target inhibitors for SARS-CoV-2 main protease and papain-like protease from Chebulae Fructus: in silico prediction and experimental verification by Changjian Wang, Yipeng Cao, Qi Yang, Xinyue Wang, Zhiying Yang, Jingjing Yang, Xinru Li, Bin Li, Yuefei Wang, Yuefei Wang, Min Zhang, Min Zhang

Subjects: Get full text